RSV infection study in Hong Kong adults
Part of Infections clinical trials.
This study looks at how common RSV (a virus that can cause coughing and breathing problems) is in adults with a recent respiratory infection. If you have a cough or other cold-like symptoms and are 18 or older, you might be able to help by giving a sputum and saliva sample.
Summary written for real people, not researchers, by Clin2.
Who can take part
- You are 18 years old or older
- You have a respiratory infection that you got from the community (not while in a hospital)
- You can provide a good sample of sputum (mucus you cough up) and saliva
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests how older adults' immune systems respond to a mild RSV virus given as a nasal spray. It helps researchers understand RSV and may lead to better vaccines or treatments.
This study looks at respiratory samples from adults after COVID-19 to better understand what viruses may be present and how they change over time. If you live in Hong Kong and can consent, you may be able to help researchers learn from your samples and symptoms.
This trial tests a new RSV vaccine for people aged 60 and above. RSV is a common virus that can cause serious breathing problems in older adults. The study will see if the vaccine is safe and helps protect you from RSV.
This study looks for markers in the blood that can tell how serious an RSV infection might become. If you are hospitalized with RSV and have breathing symptoms, this trial will follow your recovery and test for clues about your illness.
This study looks at how common respiratory viruses like RSV are in adults aged 50 and older in China. If you have cold or flu symptoms, you may be asked to provide samples to help researchers understand these infections better.
This study looks at how common RSV (a virus that can cause serious breathing problems) is in older adults who are hospitalized with respiratory symptoms or worsening heart/lung conditions. By joining, you help researchers understand the virus and improve care for people your age.
Hear when a new RSV trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.